-
Kozi bioCT053 all-human anti-BCMA CAR T cell injections were incorporated into the breakthrough treatment variety
Time of Update: 2021-01-16
On December 8, Kozi Bio announced that its CT053 all-human anti-BCMA in vitro CAR T cell injection was incorporated into the breakthrough therapeutic drug variety through the CDE publicity period, and that the adaptive disorder was formulated
-
Nat Med: Cancer cells can get worse when they spread to the liver, and the team reveals the reasons behind it and proposes treatments
Time of Update: 2021-01-15
study showed that hepatic metastasis tumors can use the host's external immune tolerance mechanism to develop access to immunotherapy resistance through the absence of CD8-T cells.
-
The first transcript of the 2021 stem cell epidemic came out!
Time of Update: 2021-01-15
January 5th, a new study in the journal Stem Cell Translational Medicine showed that inter-umbilical cord-filled stem cells can significantly improve survival and recovery time in patients with acute respiratory distress syndrome in neo-coronary pneumonia.
-
Blood: Short telomere length predicts non-recurrence mortality after stem cell transplantation in MDS patients
Time of Update: 2021-01-14
length in blood samples of 1,514 MDS patients prior to transplantation and assessed the correlation between telomere length and MDS disease characteristics and transplant prognostics. analysis of the correlation between telomere length and age
-
Cell Metabolism: Breakthrough! For the first time, teams such as Li Hongliang of Wuhan University
Time of Update: 2021-01-13
for the clinical use of hypertension in patients with neo-coronary pneumonia, and solve the problem of how to use drugs in the crisis of neo-crown epidemic (click to read). hormone is considered to be the only treatment currently effective in reducing
-
Stem cell therapy for severe COVID-19 patients: A double-blind placebo-controlled trial has demonstrated the effectiveness of Jadi Cells
Time of Update: 2021-01-12
Phase I/II double-blind, placebo-controlled trials treated 12 patients with severe COVID-19 patients with 100 million JadiCells intravenously on days 0 and 3, and 12 patients received placebo treatment.
-
Keystone Pharmaceuticals anti-PD-L1 single-anti-first-line treatment of non-small cell lung cancer market application was accepted by NMPA
Time of Update: 2021-01-10
phase 3 clinical trials of patients with Shugli single anti-treatment phase IV non-small cell lung cancer reached the main endpoint, and the listing application has been accepted by the State Drug Administration.
-
Bioluminescence Reporter Gene Imaging of Human Embryonic Stem Cell Survival, Proliferation, and Fate
Time of Update: 2021-01-07
In this chapter, the specific materials and methods needed for tracking stem cell proliferation with bioluminescence imaging will be described.
-
To study and analyze the new mechanism of double-folding of mouse monolithic stem cells
Time of Update: 2021-01-06
and apoptosis gene inhibition. On June 4th, Researcher Shuai Shuai of Nanca University's National Key Laboratory of Pharmaceutical Chemistry Biology, in a paper published online in Stem Cell Report by Yu Yang, a researcher at The Third
-
Research reveals new targets for slowing human stem cell aging
Time of Update: 2021-01-06
/> A study published online June 6 in the journal Protein and Cells found that SIRT7 stabilizes isochromatin structures by interoperability with nuclear membranes and isoprome proteins, thereby suppressing natural immune path pathps and slowing
-
Noel and Nord/Procyon work together to develop implantable stem cell therapy for Type 1...
Time of Update: 2021-01-06
and are working to develop treatments for type 1 diabetes for stem cell-derived insulin-producing islet-like clusters. but having the right cells is only half the solution; cells also need to be protected from the immune system of the subject to avoid
-
Gospel! New research has shown that perinatal tissue stem cells can significantly promote burn healing
Time of Update: 2021-01-06
cryogel (PRPCryogel-MSCs) in platelet-rich plasma cryogel (PRPCryogel-MSCs). , the pluripotent plateplate plasma combined interstumined stem cell group had higher wound closure rates on the 21st and 28th days compared to the control group.
-
The therapeutic potential of interstate-filled stem cells in a variety of pediatric diseases
Time of Update: 2021-01-05
a standardized program with stem cell transplantation as the core, integrating medical treatment, nursing, rehabilitation, psychology, etc., to extend the survival time of children, improve the quality of survival of children, and reduce the burden on families
-
JEM: Revealing the effects of aging on hematopoietic stem cell function
Time of Update: 2021-01-04
more detailed analysis may find that aging studies focusing on hematopoietic stem cells, which irreversibly affect the function of older HSC, have been active in mice with bone marrow transplant models.
-
BCMA CAR-T Cell Therapy! Johnson/Nanjing Legend cilta-cel submits rolling listing application in the United States: Treatment of multiple myeloma!
Time of Update: 2021-01-03
May 2018, based on the results of the LEGEND-2 study, Jansen initiated a Phase IB/II trial (NCT03548207) to assess the efficacy and safety of JNJ-4528's treatment of recurring or refracectable multiple myeloma in adults.
-
Latest Research Advances in Hematopoietic Stem Cells (No. 7)
Time of Update: 2021-01-03
, the University of Toronto and the Ontario Cancer Institute have revealed how hematopoietic stem cells (HSCs) can produce new blood cells in our lifetimes by looking at vast, unknown areas of our genetic material. these regions hold important
-
Amgen submitted a listing application to EMA for the treatment of non-small cell lung cancer with the KRAS inhibitor sotorasib
Time of Update: 2021-01-02
amgen has filed a listing application with the European Medicines Agency (EMA) seeking approval for the therapeutic treatment of KRAS G12C mutant non-small cell lung cancer (NSCLC), a research KRAS inhibitor.
-
Amgen submitted a new drug application for KRAS G12C inhibitor for the treatment of non-small cell lung cancer
Time of Update: 2021-01-02
Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation.
-
Cryopreservation of Human Embryonic Stem Cell Lines
Time of Update: 2021-01-02
Two different approaches have been adopted for the cryopreservation of human embryonic stem cells (hESCs): vitrification andconventional slow cooling/rapid warming.
-
Br J Cancer: SBI-756 and venetoclax: a new combination of B-cell lymphoma treatments
Time of Update: 2021-01-02
the study, researchers tested the sensitivity of cap-dependent mRNA translation inhibitors to the apoptosis effects of DLBCL and sleeve lymphoma (MCL).
